FFT Wealth Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $430K | Sell |
5,035
-7,240
| -59% | -$618K | 0.08% | 73 |
|
|
2025
Q1 | $996K | Sell |
12,275
-4,816
| -28% | -$391K | 0.21% | 51 |
|
|
2024
Q4 | $1.54M | Sell |
17,091
-1,025
| -6% | -$92.3K | 0.12% | 51 |
|
|
2024
Q3 | $1.79M | Sell |
18,116
-2,763
| -13% | -$273K | 0.14% | 49 |
|
|
2024
Q2 | $1.94M | Sell |
20,879
-1,511
| -7% | -$140K | 0.17% | 43 |
|
|
2024
Q1 | $2.12M | Sell |
22,390
-685
| -3% | -$65K | 0.18% | 42 |
|
|
2023
Q4 | $2.06M | Sell |
23,075
-882
| -4% | -$78.8K | 0.18% | 37 |
|
|
2023
Q3 | $1.75M | Sell |
23,957
-1,762
| -7% | -$129K | 0.23% | 31 |
|
|
2023
Q2 | $2.14M | Sell |
25,719
-17,405
| -40% | -$1.45M | 0.27% | 28 |
|
|
2023
Q1 | $3.29M | Sell |
43,124
-8,084
| -16% | -$616K | 0.41% | 25 |
|
|
2022
Q4 | $4.25M | Buy |
51,208
+7,467
| +17% | +$620K | 0.55% | 25 |
|
|
2022
Q3 | $3.47M | Buy |
43,741
+6,799
| +18% | +$539K | 0.48% | 21 |
|
|
2022
Q2 | $2.74M | Buy |
36,942
+31,915
| +635% | +$2.37M | 0.31% | 25 |
|
|
2022
Q1 | $452K | Buy |
+5,027
| New | +$452K | 0.04% | 40 |
|